MetaADEDB 2.0 @ LMMD
Povidone-Iodine
(CPKVUHPKYQGHMW-UHFFFAOYSA-N)
Structure
SMILES
C=CN1CCCC1=O.II
Molecular Formula:
C6H9I2NO
Molecular Weight:
364.951
Log P:
2.4616
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
0
TPSA:
20.31
CAS Number(s):
25655-41-8
Synonym(s)
1.
Povidone-Iodine
2.
PVP-Iodine
3.
Polyvinylpyrrolidone Iodine
4.
Alphadine
5.
Betadine
6.
Betaisodona
7.
Disadine
8.
Isodine
9.
PVP-I
10.
Pharmadine
11.
Providine
12.
Alphadines
13.
Betadines
14.
Disadines
15.
Isodines
16.
PVP Iodine
17.
PVP-Iodines
18.
Pharmadines
19.
Polyvinylpyrrolidone Iodines
20.
Povidone Iodine
21.
Povidone-Iodines
22.
Providines
External Link(s)
MeSHD011206
PubChem Compound410087
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypersensitivityFAERS: 46US FAERS
2EndophthalmitisFAERS: 19OFFSIDES
US FAERS
3ErythemaFAERS: 11
Canada Vigilance: 5		Canada Vigilance
US FAERS
4Eye painFAERS: 9OFFSIDES
US FAERS
5PruritusFAERS: 8
Canada Vigilance: 2		Canada Vigilance
US FAERS
6UrticariaFAERS: 8
Canada Vigilance: 1		Canada Vigilance
US FAERS
7Eye irritationFAERS: 6US FAERS
8Product quality issueFAERS: 6OFFSIDES
US FAERS
9Chemical burn of skinFAERS: 5US FAERS
10PainFAERS: 5US FAERS
11Application site reactionFAERS: 4
Canada Vigilance: 2		Canada Vigilance
US FAERS
12Skin test positiveFAERS: 4US FAERS
13Visual ImpairmentFAERS: 4US FAERS
14Cardiac ArrestFAERS: 3US FAERS
15Caustic injuryFAERS: 3OFFSIDES
US FAERS
16Corneal OpacityFAERS: 3US FAERS
17Eye allergyFAERS: 3US FAERS
18Eyelid irritationFAERS: 3US FAERS
19Punctate keratitisFAERS: 3OFFSIDES
US FAERS
20Throat irritationFAERS: 3US FAERS
21Ventricular FibrillationFAERS: 3US FAERS
22Accidental exposure to productFAERS: 2US FAERS
23AngioedemaFAERS: 2OFFSIDES
US FAERS
24DermatitisFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
25Drug exposure during pregnancyFAERS: 2US FAERS
26Drug ineffectiveFAERS: 2US FAERS
27HeadacheFAERS: 2US FAERS
28HypotensionFAERS: 2US FAERS
29InfectionFAERS: 2US FAERS
30Maternal exposure during deliveryFAERS: 2US FAERS
31Metabolic acidosisFAERS: 2US FAERS
32OverdoseFAERS: 2US FAERS
33Procedural complicationFAERS: 2US FAERS
34Septic ShockFAERS: 2US FAERS
35Unevaluable eventFAERS: 2US FAERS
36Accidental exposureFAERS: 1US FAERS
37Allergy test positiveFAERS: 1US FAERS
38Anaphylactic shockFAERS: 1US FAERS
39AnuriaFAERS: 1US FAERS
40Apparent deathFAERS: 1US FAERS
41Application site burnFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
42AstheniaFAERS: 1US FAERS
43AtelectasisFAERS: 1US FAERS
44Back PainFAERS: 1US FAERS
45Blood cholesterol increasedFAERS: 1US FAERS
46Blood osmolarity increasedFAERS: 1US FAERS
47Blood triglycerides increasedFAERS: 1US FAERS
48BronchospasmFAERS: 1US FAERS
49Burning sensationFAERS: 1US FAERS
50CandidiasisFAERS: 1US FAERS
51Cardiac fibromaFAERS: 1US FAERS
52Carpal Tunnel SyndromeFAERS: 1US FAERS
53CheilitisFAERS: 1OFFSIDES
US FAERS
54Congenital HypothyroidismFAERS: 1OFFSIDES
US FAERS
55ConjunctivitisFAERS: 1US FAERS
56Consciousness fluctuatingFAERS: 1US FAERS
57Contraindicated product administeredFAERS: 1US FAERS
58Disseminated Intravascular CoagulationFAERS: 1US FAERS
59DiverticulitisFAERS: 1US FAERS
60Drug level increasedFAERS: 1US FAERS
61Dry skinFAERS: 1OFFSIDES
US FAERS
62EcchymosisFAERS: 1US FAERS
63EczemaFAERS: 1OFFSIDES
US FAERS
64Emotional disorderFAERS: 1US FAERS
65Epidermal necrosisFAERS: 1US FAERS
66EpidermolysisFAERS: 1US FAERS
67EpilepsyFAERS: 1US FAERS
68FatigueFAERS: 1US FAERS
69FibromyalgiaFAERS: 1US FAERS
70Flavobacterium infectionFAERS: 1US FAERS
71FlushingFAERS: 1US FAERS
72Food AllergyFAERS: 1US FAERS
73Foreign body sensation in eyesFAERS: 1US FAERS
74GangreneFAERS: 1US FAERS
75HyperthyroidismFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
76Iatrogenic injuryFAERS: 1US FAERS
77Incorrect route of drug administrationFAERS: 1US FAERS
78Intestinal ObstructionFAERS: 1US FAERS
79Limb injuryFAERS: 1US FAERS
80Limb operationFAERS: 1US FAERS
81MalaiseFAERS: 1US FAERS
82Medication ErrorFAERS: 1US FAERS
83Mental status changesFAERS: 1US FAERS
84Nasal discomfortFAERS: 1US FAERS
85Ocular discomfortFAERS: 1US FAERS
86Oropharyngeal swellingFAERS: 1US FAERS
87PallorFAERS: 1US FAERS
88Penile swellingFAERS: 1US FAERS
89Peritoneal DialysisFAERS: 1US FAERS
90Pharmaceutical product complaintFAERS: 1US FAERS
91PneumoniaFAERS: 1US FAERS
92Product container issueFAERS: 1US FAERS
93Product contamination microbialFAERS: 1US FAERS
94Productive CoughFAERS: 1US FAERS
95PrurigoFAERS: 1US FAERS
96Renal failure neonatalFAERS: 1US FAERS
97Renal tubular necrosisFAERS: 1OFFSIDES
US FAERS
98Respiratory FailureFAERS: 1US FAERS
99SepsisFAERS: 1US FAERS
100ShockFAERS: 1US FAERS
101Skin UlcerFAERS: 1US FAERS
102Skin irritationFAERS: 1US FAERS
103Skin necrosisFAERS: 1US FAERS
104Status EpilepticusFAERS: 1US FAERS
105Stevens-Johnson SyndromeFAERS: 1OFFSIDES
US FAERS
106Superficial injury of eyeFAERS: 1US FAERS
107SwellingFAERS: 1US FAERS
108Thermal burnFAERS: 1
Canada Vigilance: 6		Canada Vigilance
US FAERS
109VomitingFAERS: 1US FAERS
110Wound dehiscenceFAERS: 1US FAERS
111nervous system disorderFAERS: 1US FAERS
112Abdominal Compartment SyndromeOFFSIDES
113Abdominal sepsisOFFSIDES
114AbscessOFFSIDES
115AcidosisOFFSIDES
116AcneOFFSIDES
117Acute otitis mediaOFFSIDES
118AgeusiaOFFSIDES
119Alanine Aminotransferase IncreasedOFFSIDES
120AlveolitisOFFSIDES
121Anticholinergic SyndromeOFFSIDES
122ApathyOFFSIDES
123AppendicitisOFFSIDES
124Application site irritationCanada Vigilance: 1Canada Vigilance
OFFSIDES
125Application site vesiclesCanada Vigilance: 1Canada Vigilance
126AscitesOFFSIDES
127Atrial FibrillationCanada Vigilance: 1Canada Vigilance
128Bacterial test positiveOFFSIDES
129Biliary cirrhosisOFFSIDES
130BlepharitisOFFSIDES
131Blood alkaline phosphatase increasedOFFSIDES
132Blood beta-D-glucan increasedOFFSIDES
133Blood creatine phosphokinase increasedOFFSIDES
134Blood creatinine increasedOFFSIDES
135Blood fibrinogenOFFSIDES
136Blood lactate dehydrogenase increasedOFFSIDES
137Blood pressure immeasurableOFFSIDES
138Body TemperatureOFFSIDES
139Bone fistulaOFFSIDES
140Brain DeathOFFSIDES
141Cardiac HypertrophyOFFSIDES
142CholecystitisOFFSIDES
143ColitisOFFSIDES
144Congenital mitochondrial cytopathyOFFSIDES
145Conjunctival depositOFFSIDES
146Corneal UlcerOFFSIDES
147Cystitis1009330CTD
148Cytomegalovirus test positiveOFFSIDES
149Denture wearerOFFSIDES
150Detachment of retinal pigment epitheliumOFFSIDES
151DysuriaOFFSIDES
152Ear discomfortOFFSIDES
153EnterocolitisOFFSIDES
154Erythema MultiformeOFFSIDES
155ExophthalmosOFFSIDES
156Eye inflammationOFFSIDES
157Eyelid painOFFSIDES
158FasciitisOFFSIDES
159Food PoisoningOFFSIDES
160Gamma-Glutamyltransferase IncreasedOFFSIDES
161Gastrointestinal motility disorderOFFSIDES
162Gastrointestinal perforationOFFSIDES
163Gene MutationOFFSIDES
164General physical health deteriorationOFFSIDES
165Gingival erythemaOFFSIDES
166GlaucomaOFFSIDES
167GlobulinuriaOFFSIDES
168Gum neoplasm malignant stage unspecifiedOFFSIDES
169HiccoughOFFSIDES
170Human herpes virus 6 serology positiveOFFSIDES
171HypercapniaOFFSIDES
172HypoxiaOFFSIDES
173Idiopathic urticariaOFFSIDES
174ImmunosuppressionOFFSIDES
175Increased viscosity of bronchial secretionOFFSIDES
176IndurationOFFSIDES
177InflammationCanada Vigilance: 1Canada Vigilance
178Interleukin-2 receptor increasedOFFSIDES
179Intestinal PerforationOFFSIDES
180Intraocular inflammationOFFSIDES
181Iodine allergyOFFSIDES
182IridocyclitisOFFSIDES
183Leukopenia neonatalOFFSIDES
184Limb discomfortOFFSIDES
185Lung consolidationOFFSIDES
186Malignant neoplasm progressionOFFSIDES
187MucormycosisOFFSIDES
188Muscle abscessOFFSIDES
189Musculoskeletal stiffnessOFFSIDES
190MyringitisOFFSIDES
191NasopharyngitisOFFSIDES
192Nephrotic SyndromeOFFSIDES
193Neutrophil count decreasedOFFSIDES
194OliguriaOFFSIDES
195Oral pruritusOFFSIDES
196Oropharyngeal discomfortOFFSIDES
197Oropharyngeal painOFFSIDES
198OsteolysisOFFSIDES
199OsteomyelitisOFFSIDES
200ParophthalmiaOFFSIDES
201PericarditisOFFSIDES
202PeritonitisOFFSIDES
203PeritonsillitisOFFSIDES
204Pharyngolaryngeal discomfortOFFSIDES
205Portal HypertensionOFFSIDES
206Portal Vein ThrombosisOFFSIDES
207Primary sequestrumOFFSIDES
208Procedural site reactionCanada Vigilance: 1Canada Vigilance
209Protein-losing gastroenteropathyOFFSIDES
210Psychiatric symptomOFFSIDES
211Purulent dischargeOFFSIDES
212Pyogenic granulomaOFFSIDES
213Rash erythematousCanada Vigilance: 2Canada Vigilance
214Renal tubular disorderOFFSIDES
215Retinogram abnormalOFFSIDES
216RhinorrheaOFFSIDES
217SchizophreniaOFFSIDES
218Secondary sequestrumOFFSIDES
219SequestrectomyOFFSIDES
220Sjogren's SyndromeOFFSIDES
221Sleep TalkingOFFSIDES
222SnoringOFFSIDES
223Splenic vein thrombosisOFFSIDES
224Staphylococcal abscessOFFSIDES
225Stem cell transplantOFFSIDES
226Steroid withdrawal syndromeOFFSIDES
227Tinea PedisOFFSIDES
228Tooth ExtractionOFFSIDES
229Toxic anterior segment syndromeOFFSIDES
230Tryptase increasedOFFSIDES
231Upper respiratory tract inflammationOFFSIDES
232Ureteric anastomosis complicationOFFSIDES
233UvulitisOFFSIDES
234Vascular insufficiencyOFFSIDES
235Venous InsufficiencyOFFSIDES
236VitritisOFFSIDES
237VulvitisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.